BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 26629827)

  • 1. Hyperreactivity of Blood Leukocytes in Patients with NAFLD to Ex Vivo Lipopolysaccharide Treatment Is Modulated by Metformin and Phosphatidylcholine but Not by Alpha Ketoglutarate.
    Zwolak A; Szuster-Ciesielska A; Daniluk J; Słabczyńska O; Kandefer-Szerszeń M
    PLoS One; 2015; 10(12):e0143851. PubMed ID: 26629827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Changes the Relationship between Blood Monocyte Toll-Like Receptor 4 Levels and Nonalcoholic Fatty Liver Disease-Ex Vivo Studies.
    Zwolak A; Słabczyńska O; Semeniuk J; Daniluk J; Szuster-Ciesielska A
    PLoS One; 2016; 11(3):e0150233. PubMed ID: 26930651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
    Arias-Loste MT; Iruzubieta P; Puente Á; Ramos D; Santa Cruz C; Estébanez Á; Llerena S; Alonso-Martín C; San Segundo D; Álvarez L; López Useros A; Fábrega E; López-Hoyos M; Crespo J
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD.
    du Plessis J; Korf H; van Pelt J; Windmolders P; Vander Elst I; Verrijken A; Hubens G; Van Gaal L; Cassiman D; Nevens F; Francque S; van der Merwe S
    PLoS One; 2016; 11(12):e0166048. PubMed ID: 27992443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exenatide ameliorates experimental non-alcoholic fatty liver in rats via suppression of toll-like receptor 4/NFκB signaling: Comparison to metformin.
    Saad ZA; Khodeer DM; Zaitone SA; Ahmed AAM; Moustafa YM
    Life Sci; 2020 Jul; 253():117725. PubMed ID: 32348835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic TLR4 signaling in obese NAFLD.
    Sharifnia T; Antoun J; Verriere TG; Suarez G; Wattacheril J; Wilson KT; Peek RM; Abumrad NN; Flynn CR
    Am J Physiol Gastrointest Liver Physiol; 2015 Aug; 309(4):G270-8. PubMed ID: 26113297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
    Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
    Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
    Aragonès G; Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Armengol S; Sabench F; Ras R; Hernandez M; Aguilar C; Colom J; Sirvent JJ; Del Castillo D; Richart C
    PLoS One; 2016; 11(4):e0154601. PubMed ID: 27123846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dialyzable leukocyte extract differentially regulates the production of TNFalpha, IL-6, and IL-8 in bacterial component-activated leukocytes and endothelial cells.
    Ojeda MO; van't Veer C; Fernández Ortega CB; Araña Rosainz Mde J; Buurman WA
    Inflamm Res; 2005 Feb; 54(2):74-81. PubMed ID: 15750714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fetuin-A: a novel link between obesity and related complications.
    Trepanowski JF; Mey J; Varady KA
    Int J Obes (Lond); 2015 May; 39(5):734-41. PubMed ID: 25468829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased production of IL-1alpha and TNF-alpha in lipopolysaccharide-stimulated blood from obese patients with non-alcoholic fatty liver disease.
    Poniachik J; Csendes A; Díaz JC; Rojas J; Burdiles P; Maluenda F; Smok G; Rodrigo R; Videla LA
    Cytokine; 2006 Mar; 33(5):252-7. PubMed ID: 16564703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of simvastatin or its combination with ezetimibe on Toll-like receptor expression and lipopolysaccharide - induced cytokine production in monocytes of hypercholesterolemic patients.
    Moutzouri E; Tellis CC; Rousouli K; Liberopoulos EN; Milionis HJ; Elisaf MS; Tselepis AD
    Atherosclerosis; 2012 Dec; 225(2):381-7. PubMed ID: 23062767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.
    Gangarapu V; Ince AT; Baysal B; Kayar Y; Kılıç U; Gök Ö; Uysal Ö; Şenturk H
    Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):840-5. PubMed ID: 26043290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
    Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
    Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
    Linden MA; Lopez KT; Fletcher JA; Morris EM; Meers GM; Siddique S; Laughlin MH; Sowers JR; Thyfault JP; Ibdah JA; Rector RS
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1038-47. PubMed ID: 26394261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cytokine production in human T cells and monocytes by highly purified lipoteichoic acid: involvement of Toll-like receptors and CD14.
    Ellingsen E; Morath S; Flo T; Schromm A; Hartung T; Thiemermann C; Espevik T; Golenbock D; Foster D; Solberg R; Aasen A; Wang J
    Med Sci Monit; 2002 May; 8(5):BR149-56. PubMed ID: 12011760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intake of moderate fat-enriched diet induces fatty liver and low-grade inflammation without obesity in rabbits.
    Sigrist-Flores SC; Ponciano-Gómez A; Pedroza-González A; Gallardo-Ortíz IA; Villalobos-Molina R; Pardo-Vázquez JP; Saucedo-Campos AD; Jiménez-Flores R; Méndez-Cruz AR
    Chem Biol Interact; 2019 Feb; 300():56-62. PubMed ID: 30639268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.